ArticleCancer management and research2019

Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapy.

Jinling Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.